Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TC-510 |
Synonyms | |
Therapy Description |
TC-510 are autologous T-lymphocytes engineered to express both an anti-mesothelin (MSLN) antibody fused to the N-terminus of the CD3-epsilon subunit of the T-cell receptor complex as well as a PD-1:CD28 switch receptor, which potentially induce activation of T-lymphocytes, decrease PD-1/PD-L1 pathway-dependent T-cell suppression, and induce killing of tumor cells expressing MSLN (NCI Drug Dictionary). |